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Modulation of voltage-gated Ca2+ channels controls
activitiesof excitablecells.Weshowthathigh-voltage
activated Ca2+ channels are regulated by membrane
phosphatidylinositol 4,5-bisphosphate (PIP2) with
different sensitivities. Plasma membrane PIP2 deple-
tionby rapamycin-induced translocationof an inositol
lipid 5-phosphatase or by a voltage-sensitive 5-phos-
phatase (VSP) suppressesCaV1.2 andCaV1.3 channel
currents by35%andCaV2.1 and CaV2.2 currents by
29% and 55%, respectively. Other CaV channels are
less sensitive. Inhibition is not relieved by strong
depolarizingprepulses. It changes the voltagedepen-
dence of channel gating little. Recovery of currents
from inhibition needs intracellular hydrolysable ATP,
presumably for PIP2 resynthesis. When PIP2 is in-
creased by overexpressing PIP 5-kinase, activation
and inactivation of CaV2.2 current slow and voltage-
dependent gating shifts to slightly higher voltages.
Thus, endogenous membrane PIP2 supports high-
voltage activated L-, N-, and P/Q-typeCa2+ channels,
and stimuli that activate phospholipase C deplete
PIP2 and reduce those Ca
2+ channel currents.
INTRODUCTION
Voltage-gated Ca2+ (CaV) channels mediate Ca
2+ influx in
response to membrane depolarization and regulate many phys-
iological phenomena including neurotransmission, secretion,
muscle contraction, and gene expression (Catterall et al.,
2005). The activity of CaV channels is dynamically regulated by
receptor-dependent signals, such as G proteins, protein
kinases, calmodulin, soluble N-ethylmaleimide-sensitive fusion
attachment receptor (SNARE) proteins, and the secondmessen-
gers Ca2+ and arachidonic acid (Catterall, 2000; Dolphin, 2003;
Roberts-Crowley et al., 2009). Here, we analyze in detail the
regulation of three high-voltage activated (HVA) Ca2+ channels
(CaV1.2, CaV1.3, and CaV2.2) by the plasma membrane phos-
pholipid phosphatidylinositol 4,5-bisphosphate (PIP2).224 Neuron 67, 224–238, July 29, 2010 ª2010 Elsevier Inc.Signals from G protein-coupled receptors (GPCRs) suppress
N-type CaV2.2 channels through two pathways in sympathetic
neurons (Hille, 1994). The ‘‘fast’’ pathway is voltage dependent,
membrane delimited, and insensitive to the intracellular Ca2+
chelator BAPTA. The fast suppression is induced by activating
receptors coupled to the pertussis toxin (PTX)-sensitive G
proteins Go and Gi. It can be relieved by applying large positive
pulses (Bean, 1989; Lipscombe et al., 1989; Zamponi and
Snutch, 1998) and is understood as direct voltage-dependent
binding of G protein bg subunits to N-type (CaV2.2) and P/
Q-type (CaV2.1) Ca
2+ channels (Herlitze et al., 1996; Ikeda,
1996; Dolphin, 2003). By contrast, the ‘‘slow’’ pathway is voltage
independent, insensitive to PTX, and sensitive to BAPTA.
Activation of Gq-coupled receptors initiates the slow pathway
(Bernheim et al., 1991; Delmas et al., 2005; Michailidis et al.,
2007; Roberts-Crowley et al., 2009). While the fast and slow
pathways both reduce the current appreciably, neither fully elim-
inates it. A phenomenologically similar slow pathway also
produces inhibitory modulation of L-type Ca2+ channels and
M-type (KCNQ) K+ channels by Gq-coupled receptors in sympa-
thetic neurons (Mathie et al., 1992) and in reconstituted systems
(Shapiro et al., 2000; Bannister et al., 2002). We have speculated
that the underlying signaling for slow suppression of these Ca2+
and K+ channels might be the same (Bernheim et al., 1991;
Mathie et al., 1992; Hille, 1994). Here, we ask if some or all of
the slow suppression of Ca2+ currents is due to receptor-medi-
ated depletion of PIP2, as is true for slow suppression of
KCNQ K+ current (Suh and Hille, 2002; Zhang et al., 2003; Brown
et al., 2007).
Currents in the CaV2 channel family can be modulated by
exogenous manipulation of membrane phosphoinositides (see
reviews Delmas et al., 2005; Michailidis et al., 2007). Wu et al.
(2002) concluded that depletion of membrane PIP2 underlies
a significant rundown of CaV2.1 (P/Q-type) currents seen in
inside-out excised patch experiments. They showed that appli-
cation of PIP2 antibody to the intracellular side of giant
membrane patches accelerates the CaV2.1 current rundown,
whereas a brief application of PIP2 or Mg-ATP retards the
rundown. However, unexpectedly, they also reported that
applied PIP2 reduced the currents. The ‘‘inhibitory’’ effect of
PIP2 was actually a strong positive shift of channel voltage
dependence (by 40 mV). It was antagonized by conditions
that activated cyclic AMP-dependent protein kinase. In
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2+ Channelssubsequent studies, Gamper et al. (2004) reported that CaV2.2
N-type channels are also regulated by PIP2. Macroscopic
current rundown was significantly slowed by the application of
PIP2 to the intracellular side of excised membrane patches
from Xenopus oocytes. In sympathetic neurons, the current
suppression during muscarinic receptor activation was attenu-
ated and slowed by intracellular perfusion of short-chain
DiC8-PIP2. When the N-type Ca
2+ currents were inhibited by
Gq-coupled receptor activation, current recovery was blocked
by 50 mMwortmannin to inhibit PI 4-kinase. Thus, they proposed
that depletion of PIP2 on the plasma membrane is the cause of
theGq receptor-mediated slow inhibition of N-type Ca
2+ currents
in sympathetic neurons. The PIP2 hypothesis has never been
tested for L-, R-, or T-type channels in any system. In contrast,
others have attributed the slow receptor-mediated inhibition of
both N-type and L-type Ca2+ channels to production of
arachidonic acid (Liu and Rittenhouse, 2003; Liu et al., 2006;
Roberts-Crowley et al., 2009). Thus, whether PIP2 depletion
is a major physiological signal for slow receptor-mediated
suppression of N- and L-type Ca2+ channels remains controver-
sial (Michailidis et al., 2007).
Gq-coupled receptor signals are notoriously difficult to dissect
because they produce so many downstream second messen-
gers. For example, in studies of Gq modulation of Ca
2+ channels,
PIP2 depletion occurs simultaneously with the downstream
production of arachidonic acid, activation of protein kinase C,
and elevation of cytoplasmic free Ca2+, which are all believed
to have significant effects on the channels. In order to test the
PIP2 hypothesis unambiguously, we here use two strategies to
deplete PIP2 enzymatically and rapidly without producing the
downstream products of PLC. We take advantage of two exog-
enous polyphosphoinositide 5-phosphatase systems that can
convert PI(4,5)P2 directly to PI(4)P in the plasma membrane in
living cell systems without activation of receptors. One system
uses ‘‘chemical dimerization,’’ and the other uses membrane
depolarization to activate transfected 5-phosphatase enzymes
that convert PIP2 to PIP. In chemical dimerization, addition of
rapamycin or its analog iRap to the extracellular medium
induces irreversible translocation of a transfected yeast
INP54p 5-phosphatase from cytosol to membrane, initiating
PIP2 dephosphorylation (Suh et al., 2006; Varnai et al., 2006).
The translocation and dephosphorylation take 10–20 s. The
other system uses a transfected voltage-sensitive phosphatase
(VSP), an integral plasma membrane protein that becomes
active when its N-terminal voltage-sensor domain detects large
membrane depolarization (Murata et al., 2005; Halaszovich
et al., 2009; Okamura et al., 2009). We find that the VSP system
is faster, depleting plasma membrane PIP2 within a second of
activation, and the enzyme turns off quickly when the membrane
is repolarized.
Here, we focus on the PIP2 hypothesis and reserve examina-
tion of other messengers for later work. We consider N-type
Ca2+ channels, which together with P/Q-type channels were
the subject of the previous studies (Wu et al., 2002; Gamper
et al., 2004; Lechner et al., 2005), and we consider two L-type
channels whose PIP2 dependence has not been studied before.
In addition, we screen the other subtypes of CaV channels. We
find that PIP2 depletion attenuates both L- and N-type Ca
2+channel activity through voltage-independent pathways, and
increases the susceptibility of the channels to voltage-
dependent inactivation (VDI). We also find that resynthesis of
PIP2 from PIP is needed for CaV channel recovery. Our experi-
ments show that by itself PIP2 depletion does depress HVA
Ca2+ channel activity in living cells.
RESULTS
Our goal was to test the hypothesis that Ca2+ channels respond
to depletion and resynthesis of PIP2 in living cells. To establish
conditions for recording Ca2+ channel currents, we expressed
CaV1.3 (a1D) or CaV2.2 (a1B) channel subunits together with
b3 and a2d1 accessory subunits in tsA cells and recorded the
whole-cell currents with Ba2+ as the charge carrier. Depolarizing
voltage steps from a holding potential of –70 mV evoked inward
currents carried by Ba2+ (Figure 1A). Barium was used to
minimize Ca2+-dependent inactivation of the current so that
any current decay observed during the test pulses would be
due primarily to voltage-dependent inactivation (VDI). As ex-
pected, the CaV1.3 currents inactivated little during the 40 ms
test pulses, whereas the CaV2.2 currents inactivated more.
Peak current-voltage (I-V) relations showed that CaV1.3
currents peaked near –10 mV (n = 6), whereas CaV2.2 currents
peaked near +10 mV (n = 8) (Figure 1B). These respective peak
voltages were used for all test pulses in subsequent experi-
ments to assay the function of these channels, except where
indicated.
Chemical Translocation of a PIP2 5-Phosphatase
to the Plasma Membrane Attenuates CaV Currents
We begin with the chemical dimerization system and iRap to
deplete membrane PIP2. In addition to the channel subunits
and the M1 muscarinic receptor, two additional components
needed to be cotransfected: the membrane-localized iRap-
binding protein Lyn11-FRB (LDR) and the fluorescent cyto-
plasmic enzyme construct CFP-FKBP-INP54p (CF-Inp). The
CF-Inp has PIP2 5-phosphatase activity that converts PIP2 to
PI(4)P. We showed previously that when LDR and CF-Inp are
brought together at the membrane by application of iRap, PIP2
is irreversibly depleted and PIP2-dependent KCNQ K
+ channels
turn off (Suh et al., 2006). This system is suitable for experimental
designs that benefit from the irreversible PIP2 depletion that
follows chemical dimerization.
As an initial control, when CF-Inp is expressed but the
membrane anchor LDR is omitted (LDR), iRap had little direct
effect on the currents (top panels in Figures 1C and 1D), although
both channels were readily inhibited by M1 receptor activation
with the muscarinic agonist Oxo-M. When LDR was included
(+LDR), there were two changes. First, currents in Ca2+ channels
were decreased irreversibly by iRap (bottom panels in Figures
1C and 1D), a decrease that was less than had been seen with
muscarinic receptor activation. The second effect was alteration
of the subsequent response to muscarinic receptor activation.
Prior PIP2 depletion by activated INP54p 5-phosphatase
eliminated further inhibition of CaV1.3 current by muscarinic
receptors (Figure 1C), quite possibly because the irreversible
depletion of PIP2 abrogates muscarinic generation of all PIP2Neuron 67, 224–238, July 29, 2010 ª2010 Elsevier Inc. 225
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Figure 1. PIP2 Depletion Depresses CaV1.3
and CaV2.2 Voltage-Gated Ba
2+ Currents
(A) Families of whole-cell Ba2+ currents elicited by
voltage steps from –80 to +50 mV in 10 mV inter-
vals (see pulse protocol) in cells expressing
CaV1.3 (left) and CaV2.2 (right) channels. Holding
potential is –70 mV and dashed line is zero current.
Closed arrowheads indicate peak inward Ba2+
currents triggered by the depolarizing test pulses.
Tail currents are clipped.
(B) Peak current-voltage (I-V) relations for CaV1.3
and CaV2.2 currents in whole-cell recording
normalized to the maximum current. Points are
mean ± SEM (CaV1.3, n = 6; CaV2.2, n = 8).
(C and D) Current modulation by iRap (5 mM) and
Oxo-M (10 mM) in cells coexpressing M1 musca-
rinic receptors and CF-Inp alone (top, –LDR) or
with LDR (bottom, +LDR). Currents were recorded
in response to test pulses to –10 mV (CaV1.3)
or +10 mV (CaV2.2) every 4 s. Dashed line is zero
current. LDR, membrane anchor protein. CF-Inp,
PI 5-phosphatase.
(E and F) Percent inhibition of CaV1.3 (E) and
CaV2.2 (F) currents by iRap and Oxo-M compared
to initial currents in cells expressing CF-Inp alone
(–LDR) or with LDR (+LDR). The application of
iRap significantly inhibited CaV1.3 currents
(*p < 0.05 compared to iRap effect without LDR,
n = 3 for –LDR; n = 4 for +LDR) and CaV2.2 currents
(**p < 0.01 compared to iRap effect without LDR,
n = 3 for both –LDR and +LDR). Data are mean ±
SEM. See also Figure S1.
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2+ Channelscleavage products, including inositol trisphosphate and calcium
signaling (Suh et al., 2006). On the other hand, further muscarinic
modulation of CaV2.2 current remained intact and reached full
amplitude (Figure 1D). Quite possibly that pathway does not
require PIP2. It might involve G protein bg subunits or other prod-
ucts of phospholipases including PLA2 (Melliti et al., 2001; Rob-
erts-Crowley et al., 2009). As a preliminary conclusion, musca-
rinic inhibition of both channels probably occurs via more than
one pathway, and any PIP2 depletion component accounts for
only part of the total effect.
It is well known that inhibition of CaV2.2 current by M2 musca-
rinic receptor-mediated signaling (the fast Gbg pathway) is
strongly relieved by large positive prepulses (Elmslie et al.,
1990). We readily verified this effect in cells transfected with
M2 (Gi-coupled) rather than M1 (Gq-coupled) receptors (data
not shown). Can the iRap-induced inhibition of CaV1.3 and
CaV2.2 channels also be relieved by strong depolarizing226 Neuron 67, 224–238, July 29, 2010 ª2010 Elsevier Inc.prepulses? The cells were given a
+130 mV/20 ms prepulse followed 5 ms
later by a 10 ms test pulse to measure
channel function. Figure S1 (available
online) shows that inhibition was
unchanged by the prepulses for CaV1.3
channels (Figure S1A) and for CaV2.2
channels (Figure S1B). Hence, unlike
inhibition of CaV2.2 channels via Gbg,positive prepulses do not relieve the suppression that follows
iRap-induced PIP2 depletion.
Depletion of Membrane PIP2 by Activation
of Dr-VSP Attenuates CaV Currents
We turn now to depleting PIP2 with the voltage-sensitive phos-
phatase from zebra fish (Dr-VSP; Okamura et al., 2009). This
tool is suitable for experimental designs that benefit from revers-
ible PIP2 depletion following an activating depolarization. First
we characterized the ability of Dr-VSP to deplete membrane
PIP2 by using two fluorescent PIP2 indicators and measuring
fluorescence resonance energy transfer (FRET) between them
(van der Wal et al., 2001; Jensen et al., 2009). In resting cells,
the PIP2-binding fluoroprobes CFP-tagged PH(PLCd1) and
YFP-taggedPH(PLCd1) bind to thePIP2 at theplasmamembrane
in high enough surface density to generate FRET between them
(Figure S2A). If PIP2 is depleted, the probes dissociate from the
DB
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Figure 2. Inhibition of CaV Currents by
Dr-VSP-Mediated PIP2 Depletion
(A and C) Typical traces of CaV1.3 (A) and CaV2.2
(C) currents before and after activation of Dr-VSP
by depolarizations to +120 mV. Cells without Dr-
VSP (Control), cells transfected with Dr-VSP, or
cells transfected with Dr-VSP plus PIPKIg received
a test pulse to –10 (A) or +10 mV (C) for 10 ms and
then were depolarized to +120 mV for zero or 0.5 s
(as marked), followed by a second test pulse. The
currents before (a) and after (b) the +120mV-depo-
larizing pulse are superimposed. Dashed line is
zero current.
(B and D) Time-dependent inhibition of L-type
(CaV1.3, B) and N-type (CaV2.2, D) currents by
Dr-VSP activation. Top, cells were depolarized
to +120 mV for various times and the relative
current ratio (b/a) was measured in control (open
circle, n = 6–14 for CaV1.3 and n = 6 for CaV2.2),
Dr-VSP-expressing (closed circle, n = 6–11 for
CaV1.3 and n = 6 for CaV2.2) cells, and Dr-VSP
plus PIPKIg expressing cells (n = 5–8). The delay
between subsequent test pulses was 1 min.
Bottom, percent inhibition of currents by time-
graded activation of Dr-VSP at +120 mV. See
formula in text. The current inhibition by 1 s depo-
larizing pulse is labeled in each figure. Data are
mean ± SEM. See also Figure S2.
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2+ Channelsmembrane andmove to the cytosol, losing their FRET interaction
(van der Wal et al., 2001). In cells cotransfected with Dr-VSP,
application of depolarizingpulses to+120mVactivated thephos-
phatase activity. Using 440 nm light to excite CFP, the fluores-
cenceofCFP (CFPC) increased and that of YFP (YFPC) decreased
each time the depolarization was applied (Figure S2B, top), and
PIP2 depletion was signaled as the corresponding decrease in
the FRET ratio (FRET ratio = YFPC/CFPC) (Figure S2B, bottom).
During the large depolarization, the PIP2 depletion developed
rapidly (exponential time constant t = 105 ± 18 ms, n = 9)
(Figure S2C) and in a voltage dependent manner (V1/2 = 61 ±
5mV, n=5) (FigureS2D).According to theFRETassay, thedeple-
tion with Dr-VSP is comparable to that seen with M1 muscarinic
receptor activation (Figure S2E). However, it is much faster and
results in quite different cleavage products.
As was anticipated from the PIP2 depletion, activation of
Dr-VSP decreased current in HVA Ca2+ channels. Our protocol
was to apply a standard test pulse (pulse a) to record baseline
channel current, then a large depolarizing pulse for various times
to activate Dr-VSP, followed by a second test pulse (pulse b)
(Figure 2A). In control cells not expressing Dr-VSP, CaV1.3Neuron 67, 224–current amplitudes a and b were almost
the same without (0 s) or with (0.5 s) a
0.5 s depolarization to +120 mV (Fig-
ure 2A, left). In contrast, in cells express-
ing Dr-VSP, the 0.5 s depolarizing pulse
significantly attenuated the Ba2+ current
in pulse b (Figure 2A, middle). Again, in
the same cell there was no significant
change in current b without the large
pulse. To examine whether this Dr-VSP-induced inhibition of CaV1.3 current is caused by PIP2 degrada-
tion, we tested the effect of Dr-VSP activation in cells transfected
with the PIP 5-kinase type-1g (PIPKIg). This enzyme elevates
PIP2 concentration in the plasma membrane (Wenk et al.,
2001) and thereby diminishes the ability of Gq-coupled receptors
to suppress KCNQK+ currents (Suh andHille, 2007). As shown in
Figures 2A and 2C right, the inhibition of CaV1.3 and CaV2.2
channels by Dr-VSP was significantly attenuated by PIPKIg
expression. Figure 2B plots the time dependence of the b/a
current ratio (top) and of the percent inhibition with and without
Dr-VSP (bottom). The CaV1.3 channels were maximally inhibited
by 33% with an onset time constant t = 112 ± 7 ms (Figure 2B,
bottom left). Further, PIPKIg overexpression significantly attenu-
ated the Dr-VSP-induced CaV1.3 inhibition (Figure 2B, top left).
We also performed Dr-VSP experiments with N-type CaV2.2
channels. The bottom line was similar: CaV2.2 channels were
inhibited by Dr-VSP activation with a maximum inhibition of
56% and onset t = 143 ± 10 ms (Figure 2D, bottom). However,
in these experiments there was much more evidence of channel
inactivation induced by the voltage protocols. Even in the
absence of Dr-VSP, the CaV2.2 current in pulse b was reduced238, July 29, 2010 ª2010 Elsevier Inc. 227
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Figure 3. Channel Inhibition by Dr-VSP Corrected for VDI
(A and C) Effect of membrane hyperpolarization on Dr-VSP-induced inhibition of CaV1.3 (A) and CaV2.2 (C) currents. The changes of CaV1.3 and CaV2.2 currents
by a +120 mV depolarizing pulse were measured without (–) and with (+) a hyperpolarizing step (–150 mV, 0.9 s) in control and Dr-VSP-expressing cells. Pairs of
current traces were recorded from the same cell with a 1 min interval.
(B and D) Summary of the relative peak current (b/a) of CaV1.3 (B) and CaV2.2 (D) in control andDr-VSP-expressing cells with andwithout the hyperpolarizing step.
Data are mean ± SEM (CaV1.3, n = 5–6; CaV2.2, n = 4). The percent difference between control and Dr-VSP is labeled in each condition.
(E) Effect of Dr-VSP on CaV2.2 tail currents. Tail currents were measured with a hyperpolarizing step (–150 mV, 0.4 s) in control and Dr-VSP-expressing cells.
Pairs of current traces were recorded from the same cell 1 min apart. Capacitive and leak currents were subtracted by a P/5 procedure.
(F) Summary of the tail-current inhibition (%) of CaV2.2 in control and Dr-VSP-expressing cells. Data are mean ± SEM (control, –6.1 ± 7.2, n = 5; Dr-VSP,
57.6 ± 5.2, n = 8).
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2+ Channelsby as much as 31% ± 2% (n = 6) by the preceding 0.5 s depolar-
ization to +120 mV (Figures 2C and D). Moreover, N current was
even partially reduced without (0 s) the large depolarizing pulse.
To compensate for such ‘‘control’’ inactivation, we calculated
the percent inhibition due to Dr-VSP action by the formula 100
{1  (b/a)VSP/(b/a)Control} at each time point in this figure and in
subsequent figures. This correction would apply accurately if
the ‘‘inactivation’’ seen without Dr-VSP is unchanged by the
action of Dr-VSP, an assumption that we revisit later. Hence,
Dr-VSP, like the iRap-dimerizable INP54p system, depletes PIP2
and leads to parallel depression of currents in three subtypes of
Ca2+ channels. We did find that, for CaV1.3 and CaV2.2 channels,
the mean inhibition by Dr-VSP was 35% larger than that with
the iRap system. In summary, experiments with two lipid phos-
phatases are consistent with the hypothesis that PIP2 regulates
CaV channels.
Inhibition of CaV Channels by Dr-VSP Is Not Simple VDI
We have already said that much of the current inactivation devel-
oping during test pulses in the presence of barium is voltage228 Neuron 67, 224–238, July 29, 2010 ª2010 Elsevier Inc.dependent, VDI. In Figure 3 we examined the role of VDI in our
measurements and its possible dependence on PIP2. We ask
whether some parts of the inhibition by Dr-VSP are simply an
enhancement of VDI by testing whether the inhibition can be
removed by a large hyperpolarizing pulse. The 0.9 s hyperpola-
rizing voltage step to –150 mV ended 0.1 s before test pulse
b (see pulse protocols in Figures 3A and 3C).
In control cells, CaV1.3 currents showed no or very minor VDI
from the +120-mV/1 s depolarizing pulse, i.e., in control cells,
currents a and b were very similar even without the hyperpolar-
ization. With the 150-mV hyperpolarizing voltage step, the
minor VDI was abolished (Figure 3A, top right). In cells express-
ing Dr-VSP, CaV1.3 current b was strongly reduced compared to
a, without and with the hyperpolarizing step (Figures 3A, bottom,
and 3B). Thus, CaV1.3 channels had little residual VDI from our
pulse protocol, and the inhibitory effect of Dr-VSP activation
was not relieved by hyperpolarizations. In control cells express-
ing CaV2.2 channels, there was some residual VDI after pulse
a (Figure 3C, top left). This made the pulse b currents 30%
smaller (Figures 3C and 3D). The reduction was totally relieved
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Figure 4. Screening CaV Subtypes for Modulation by
Dr-VSP and M1 Muscarinic Receptors
(A) Inhibition of CaV1.2 and 2.1 currents by Dr-VSP-induced
PIP2 depletion. CaV currents weremeasured during test pulses
before and after a +120 mV/1 s depolarizing pulse in control
and Dr-VSP-expressing cells. Typical current traces for each
channel type are superimposed.
(B) Inhibition of CaV1.2 and 2.1 currents by M1 muscarinic
receptor stimulation withOxo-M (10 mM). Insets, Typical traces
before and after Oxo-M application were superimposed.
(C) Inhibition of CaV currents by Dr-VSP-induced PIP2
depletion (top) and M1 muscarinic receptor stimulation with
Oxo-M (B). ND, not determined. *The CaV2.3 current was
enhanced 2.7 ± 0.5-fold (n = 4) by the activation of M1
receptors. Data are mean ± SEM. See also Figure S4.
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PIP2 Regulates Voltage-Gated Ca
2+ Channelsby the 150-mV/0.9 s hyperpolarization. Indeed, the current in
pulse b became larger than that in pulse a as if the hyperpolariza-
tion was also relieving some resting inactivation that had
reduced pulse a current (Figure 3C, top right). With Dr-VSP,
the large depolarizing pulse strongly depressed current in pulse
b as before. Again when compared to the control cells, the
hyperpolarizing step did not relieve any of the effect of VSP
(Figure 3D). CaV2.2 channels show prominent tail currents.
Therefore, we also could test whether the tail currents were
inhibited by Dr-VSP. Figures 3E and 3F show strong inhibition
in Dr-VSP-expressing cells. The inhibition of tail currents was
similar to that of inward currents during test pulses. Thus for
CaV1.3 and CaV2.2 channels, the depression of current due to
Dr-VSP activation did not seem to be some kind of enhancement
of VDI.
Subtype-Specificity of PIP2 Modulation of CaV Channels
We screened for channel modulation by expressing different a1
subunits with the same b3 and a2a1 channel subunits as before.NeuroFigure 4A shows that the CaV1.2 and CaV2.1
channel currents were also significantly inhibited
by Dr-VSP activation although less than for
CaV2.2 channels. Since the current-voltage rela-
tions for CaV1.2 and CaV2.1 peaked at +10 mV
and 0mV, respectively (Figure S3A), those voltages
were used for the test pulses in these experiments.
The CaV1.2 channels gave currents similar to those
with CaV1.3 and showed almost the same inhibition
by muscarinic activation (62% ± 8% for CaV1.2,
n = 5; 59% ± 3% for CaV1.3, n = 6) (Figures 4B
and 4C, bottom). Furthermore, the effects of
Dr-VSP activation were very similar (Figure 4C,
top). With CaV1.2 channels, the large depolarizing
pulse produced a 35% inhibition of current devel-
oping with an onset time constant t = 138 ± 18 ms
(n = 6). CaV2.1 channels are inhibited by both
Dr-VSP and M1 receptor stimulation (Figure 4).
However, the other subtypes of CaV channels,
1.4, 2.3, and all CaV3 (T-type), were insensitive to
Dr-VSP activation (Figures 4C and S3B). Interest-
ingly, the four PIP2-depletion-sensitive channels
were also strongly inhibited by M1 receptor activa-tion with Oxo-M, and the other channels were not significantly
inhibited by Oxo-M. Indeed CaV2.3 R-type currents were
strongly enhanced (Figure S3C).
PIP2-Dependent Modulation of CaV2.2 Channels
PIP2 dependence of CaV current modulation was investigated in
more detail with CaV2.2 channels. When the cells overexpressed
the PIP2-binding peptide scavenger, PH domain of PLCd1, the
current density in the transfected cells was significantly
decreased compared to control cells expressing only GFP or
cells expressing PH domain of Akt protein which binds to PI
(3,4)P2 and PIP3 in the plasma membrane (Figure 5A). Next, we
tested if PIP2 elevation above its normal level attenuates the
muscarinic suppression of the CaV2.2 channels. Overexpression
of PIPKIg significantly attenuated the M1 muscarinic receptor-
induced inhibition (Figure 5B) as well as the Dr-VSP-induced
CaV2.2 inhibition (Figure 2C). The muscarinic inhibition without
PIPKIg was 72% ± 8% (n = 6), and with PIPKIg it was reduced
to 35% ± 7% (n = 6).n 67, 224–238, July 29, 2010 ª2010 Elsevier Inc. 229
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Figure 5. PIP2-Dependent Modulation of CaV2.2 N-Type Channels
(A) CaV2.2 current density (pA/pF) was measured in cells expressing the CaV2.2 channels plus GFP, GFP-PH-PLCd1, or YFP-PH-Akt. The cells were transfected
with the same amounts of cDNA. Average membrane capacitances for cells are 22 ± 2 pF for GFP (n = 11), 25 ± 4 for PH-PLC (n = 11), and 24 ± 4 for PH-Akt
(n = 12). Top, confocal images of tsA cells expressing each fluorescent protein. Cell diameters were 20–30 mm. Data are mean ± SEM.
(B) Elevated PIP2 levels attenuate CaV2.2 channel inhibition by M1 receptor stimulation. CaV2.2 currents were measured in control cells and in cells transfected
with PIPKIg. Right, Summary of current inhibition by Oxo-M. Data are mean ± SEM. *p < 0.05, compared to control.
(C) Current-voltage (I-V) relations of N-type CaV current in isolated rat SCG neurons expressing Dr-VSP (n = 3) with a widefield image of one neuron. Data are
mean ± SEM.
(D) Inhibition of N-type CaV currents by Dr-VSP activation in SCG neurons. N-type CaV currents were measured during test pulses before and after a +120 mV/1 s
depolarizing pulse in control and cells expressing Dr-VSP. Capacitive and leak currents were subtracted by a P/5 procedure. Right, Summary of N-type current
inhibition by Dr-VSP activation in SCG neurons. Data are mean ± SEM (n = 3 for control, n = 3 for Dr-VSP).
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PIP2 Regulates Voltage-Gated Ca
2+ ChannelsFinally, we tested if PIP2 depletion could decrease the endog-
enous CaV2.2 N-type current of sympathetic superior cervical
ganglion (SCG) neurons. Figure 5C shows the current-voltage
relationship of N-type current in SCG neurons expressing
Dr-VSP. The current peaked at 10 mV. When the Dr-VSP was
activated by +120 mV/1 s-depolarization, it inhibited the
N-type current by 28% in SCG neurons (Figure 5D). Thus
membrane PIP2 is also important for CaV channel activity in
differentiated neurons.
Recovery from Dr-VSP-Induced Inhibition Requires
Intracellular ATP and PIP2 Resynthesis
After the Dr-VSP-induced inhibition, current recovered in <1min.
We tested the need for PIP2 synthesis in channel recovery.
Current was elicited with the voltage protocols shown in Fig-
ures 6A and 6E. Cells were given a 10 ms test pulse to measure230 Neuron 67, 224–238, July 29, 2010 ª2010 Elsevier Inc.the initial current (I0), then depolarized to +120 mV for 1 s to acti-
vate Dr-VSP. Finally, recovery from inhibition was measured by
applying 10-ms test pulses with successively longer delay after
VSP activation starting at 0.5 s as indicated above the traces.
As before, in control cells expressing CaV1.3 channels, the
current was only slightly inhibited by the large depolarizing pulse
(Figure 6A, top).With Dr-VSP, theCaV1.3 current was reduced by
thedepolarization and recovered to the initial levelwith a recovery
time constant t of 5.9 s (Figures 6A, bottom, and 6B). In control
cells expressing CaV2.2 current, the current was reduced by
VDI and then recovered (Figure 6E, top). In cells with Dr-VSP,
the current was strongly inhibited by the large depolarization
and, after correcting for control VDI, recovered with a time
constant t of 16.1 s (Figures 6E, bottom, and 6F), slower than
for CaV1.3 channels. The slower recovery of CaV2.2 compared
to CaV1.3 did not seem to be due to some form of slowly
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Figure 6. Recovery of CaV Currents after Dr-VSP-Induced Inhibition
(A and E) Current traces for CaV1.3 (A) and CaV2.2 (E) channels in control (top) and Dr-VSP-expressing (bottom) cells before and after a +120 mV/1 s depolarizing
pulse. CaV1.3 and CaV2.2 currents weremeasured at –10mV and +10mV, respectively, at the indicated times after the +120-mV pulse. Dashed lines indicate zero
current, and dotted lines, the initial CaV current before the depolarization step.
(B and F) Time course of recovery of CaV1.3 and CaV2.2 currents after the Dr-VSP-induced inhibition in control (open circles) and Dr-VSP-expressing
(closed circles) cells. Data are mean ± SEM (CaV1.3, n = 6 for both control and Dr-VSP; CaV2.2, n = 5 for both). Inset shows % current relative to control cells.
(C and G) Time course of CaV1.3 and CaV2.2 current recovery in cells transfected with PIPKIg (CaV1.3, n = 5 for control and n = 8 for Dr-VSP; CaV2.2, n = 4 for
control and n = 5 for Dr-VSP). Inset shows % current, comparing Dr-VSP to control cells. Data are mean ± SEM.
(D and H) Time course of CaV1.3 and CaV2.2 current recovery with 3 mM AMP-PCP instead of ATP in the pipette solution. Data are mean ± SEM (CaV1.3, n = 7 for
control and n = 10 for Dr-VSP; CaV2.2, n = 6 for control and n = 5 for Dr-VSP). Insets show the%current recovery in the presence of AMP-PCP. See also Figure S4.
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PIP2 Regulates Voltage-Gated Ca
2+ Channelsrecovering VDI, since it was not significantly relieved or speeded
by a –150-mV hyperpolarizing step (Figure S4A).
We next tested the hypothesis that PIP2 resynthesis is needed
for CaV current recovery from the Dr-VSP-induced inhibition.
First we speeded resynthesis. Coexpression of the 5-kinase
PIPKIg withCaV1.3 or CaV2.2 channels significantly decreased
the current inhibition with the +120 mV/1 s pulse and speeded
the current recovery (Figures 6B, 6C, 6F, and 6G). Next we
slowed PIP2 resynthesis. The synthesis of PIP2 from PI(4)P
requires intracellular ATP, so we slowed the kinase activity by
dialyzing the nonhydrolyzable ATP analog AMP-PCP into the
cell. The inclusion of 3 mM AMP-PCP instead of ATP in the
pipette solution did not significantly affect maximum channel
inhibition but strongly slowed the recovery of both CaV1.3
current (t = 21 s) (Figure 6D) and CaV2.2 current (t = 32 s)
(Figure 6H) and diminished the maximum recovery (for traces,
see Figure S4B). As expected, dialyzing with AMP-PCP also
strongly slowed and depressed PIP2 resynthesis as measured
by FRET with PH-domain probes (Figure S4C). With ATP, the
Dr-VSP-induced FRET ratio changes recovered almost
completely (94% ± 3%) with a time constant t of 6.4 ± 0.9 s(n = 11), whereas with 3 mM AMP-PCP the recovery after one
large depolarizing pulse was smaller (only 58% ± 3%) and
slower with a time constant t = 32 ± 4 s (n = 5), and there
was no recovery after a second depolarizing pulse as if the
last remaining ATP had been exhausted (Figure S4D). Inclusion
of another nonhydrolyzable ATP analog AMP-PNP gave a
similar retardation of the FRET recovery (data not shown). In
summary, we find that channel recovery after PIP2 depletion
is faster when PIP2 synthesis is speeded and slower and
incomplete when PIP2 synthesis is slowed, implying that PIP2
resynthesis underlies CaV channel recovery from the VSP-medi-
ated inhibition.
Simultaneous Measurements of Channel Modulation
and PIP2 Degradation in the Same Cells
Apuzzling findingwas that recovery ofCaV1.3 channels (Figure 6)
closely paralleled that of FRET ratio measured in separate
experiments (Figure S2), whereas recovery of CaV2.2 channels
was slower than that of FRET ratio. Could it be that because
we studied one set of cells expressing PH domains and different
sets of cells expressing the channels, the comparison was notNeuron 67, 224–238, July 29, 2010 ª2010 Elsevier Inc. 231
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Figure 7. Simultaneous Measurement of CaV Current Modulation and PIP2 Depletion in Single Cells
All cells coexpress channel subunits, PH-domain probes, and Dr-VSP.
(A and B) Single-cell measurements of FRET ratio signals andwhole-cell current fromCaV1.3 (A) or CaV2.2 (B) channels. Top, time-dependent induction of Dr-VSP
effect on current and FRET ratio measured simultaneously in single cells. Bottom, superimposed time courses of current inhibition and FRET ratio decrease,
normalized.
(C) Voltage dependence of Dr-VSP action on CaV1.3 current and FRET ratio change in a single cell.
(D and E) Time course of recovery of FRET ratio signals and whole-cell current of CaV1.3 (E) or CaV2.2 (F) channels in single-cell experiments. Top, recovery of
currents and FRET ratio from the Dr-VSP-induced changes was measured simultaneously in single cells. Bottom, superimposed recoveries of current and FRET
ratio in a single cell.
(F) AMP-PCP in the pipette solution attenuates the recovery of CaV1.3 current and FRET ratio. A single cell dialyzed with 3 mM AMP-PCP was given a 3 s or 5 s
depolarizing pulse and current and FRET ratio were measured simultaneously.
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Figure 8. Modulation by Dr-VSP in a Gbg-Insensitive Chimeric CaV2.2 Channel
(A) Normalized peak current-voltage (I-V) relations of wild-type CaV2.2 (a1B) and chimeric CaV2.2 (a1C-1B) channels in the whole-cell configuration. Currents
were elicited by voltage-steps from –40 to +40 mV, in 5 mV intervals, from a holding potential of –80 mV. Points are mean ± SEM (n = 5 for both channels).
(B) Time course of M2 muscarinic receptor action (Oxo-M, 10 mM) on wild-type CaV2.2 (a1B) (top) or CaV2.2 (a1C-1B) (bottom) channels. The current amplitude
was measured at +10 mV every 4 s.
(C) Summary of the muscarinic inhibition of CaV2.2 (a1B) and CaV2.2 (a1C-1B) currents by M2Rs. Data are mean ± SEM (CaV2.2 [a1B] alone, n = 5; CaV2.2 [a1B]
with M2 receptors, n = 4; CaV2.2 [a1C-1B] with M2 receptor, n = 5).
(D) Inhibition of chimeric CaV2.2 (a1C-1B) currents by Dr-VSP. Typical traces of CaV2.2 (a1C-1B) currents before and after Dr-VSP activation by depolarization to
+120mV. Control (left) and Dr-VSP-expressing (right) cells received a test pulse and then were depolarized to +120mV for zero or 1 s (Dt), followed by the second
test pulse (b). The currents before (a) and after (b) the depolarizing pulse superimposed.
(E) Summary of the current inhibition (%) by the +120-mV depolarizing pulse in control (n = 8) and Dr-VSP-expressing (n = 5) cells. Data are mean ± SEM.
(F) Time course of current recovery from Dr-VSP-induced inhibition. Cells were depolarized to +120 mV for 1 s, and the recovery of currents was measured.
Inset shows the percent current from comparing control and Dr-VSP-expressing cells. Data are mean ± SEM (n = 6).
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2+ Channelsvalid? It seemed necessary to cotransfect PH domains and
channels and to measure the current and FRET ratio simulta-
neously in the same cell.
The following experiments show in simultaneous recordings
that the close parallels between Dr-VSP effects on CaV1.3
currents and FRET ratio changes persist. Figure 7A measures
the onset of the Dr-VSP effects with depolarizations of different
duration (Dt). The duration dependence was indistinguishable
(Figure 7A, bottom), and the ratio of the time constants for onset
(t current /t FRET) was 1.02 ± 0.09 (n = 5). Figure 7C shows the
dependence on the voltage of the pulse for VSP activation;
the mid-point voltage was 58 mV for both responses. Similarly,
the recovery time courses of current and FRET ratio after termi-
nation of the depolarizing pulse were the same (time constant
ratio 0.91 ± 0.09, n = 5; Figure 7D); when AMP-PCP replaced
ATP in the pipette, the recoveries remained parallel althoughmuch slowed (Figure 7F). On the other hand, in similar simulta-
neous recording experiments with CaV2.2 channels, differences
in time course persisted. The duration dependence for onset
showed quicker loss of current than of FRET ratio (time constant
ratio 0.65 ± 0.04, n = 4; Figure 7B), and the recovery after Dr-VSP
showed slower recovery of current (time constant ratio 3.7 ± 0.7,
n = 6; Figure 7E). These ratios ought to be interpreted cautiously
since it was not possible to correct for confounding VDI in these
experiments.
Modulation of CaV2.2 Currents by Dr-VSP
Is Not Gbg Binding
CaV2.2 (N-type, a1B) channel currents can be suppressed
by membrane Gbg subunits in a voltage-dependent manner
(Dolphin, 2003). Might the Dr-VSP-mediated channel modulation
be due in part to enhanced binding of Gbg subunits to CaV2.2Neuron 67, 224–238, July 29, 2010 ª2010 Elsevier Inc. 233
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Figure 9. PIP2 Depletion Affects Channel Inactivation and Activation
(A) Effect of Dr-VSP-induced PIP2 depletion on the rate of inactivation of CaV1.3 (left) and CaV2.2 (right) currents. CaV currents were measured during 500 ms test
pulses to –10 (CaV1.3) or +10 mV (CaV2.2) before (a) and after (b) a +120 mV/1 s depolarizing pulse in control cells (top) and in cells expressing Dr-VSP (bottom).
Green lines (b0) are b current traces scaled to the peak amplitude of a current. Bottom, summary of the time constants for current inactivation (n = 5, *p < 0.01,
compared to current a). Data are mean ± SEM.
(B) Elevated PIP2 levels slow CaV2.2 channel inactivation. CaV2.2 currents during 500 ms test pulses to +10 mV or +30 mV were measured in control cells with no
Dr-VSP and in cells transfected with PIPKIg. Typical current traces for each test voltage are overlaid.
(C) Summary of inactivation time constants (t) for CaV2.2 current during the +10 mV and +30 mV test pulses with different PIP2 levels in the plasma membrane.
Data are mean ± SEM (n = 5 for control, n = 7 for PIPKIg at both test pulses).
(D) Elevated PIP2 levels slow CaV2.2 channel activation. Activation of CaV2.2 channels during the depolarization to +10 mV was measured in control cells with no
Dr-VSP and in cells cotransfected with PIPKIg. Currents showing similar amplitude are superimposed.
(E) Current-voltage (I-V) relations of CaV2.2 channels in control (open circle) and PIPKIg-transfected (closed circle) cells. Relative currents are plotted against test
potential. Points are mean ± SEM (n = 8 for control; n = 9 for PIPKIg). See also Figure S5.
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2+ Channelschannels when membrane PIP2 is depleted? As a test we took
advantage of the Gbg subunit-insensitive chimeric channel
construct called a1C-1B (Agler et al., 2005). In this construct,
the N terminus of CaV2.2 (N-type, a1B subunit), which includes
one of the Gbg binding sites, is replaced by the N terminus of
CaV1.2 (L-type, a1C subunit) (Figure 8A). When expressed in
tsA cells, these chimeric channels activated in the same voltage
range as wild-type CaV2.2 channels but could not be inhibited by
stimulation of M2 (Gi-coupled) muscarinic receptors (Figures 8B
and 8C). The wild-type CaV2.2 channels were readily inhibited
(78% ± 5%, n = 5). In cells expressing the chimeric channels
and Dr-VSP, a +120-mV/1 s depolarizing pulse strongly inhibited
the current by 56% when corrected for VDI seen in control cells
(Figures 8D and 8E). Following the inhibition, the chimeric chan-
nels recovered with a time constant t of 15 s (Figure 8F), compa-
rable to the wild-type channels (Figure 6F). These experiments
give no evidence for enhanced binding of Gbg subunits to the
channel when PIP2 is depleted. They also show that replacing
the N terminus of the CaV2.2 with that of CaV1.2 subunits does
not change PIP2-mediated channel modulation.234 Neuron 67, 224–238, July 29, 2010 ª2010 Elsevier Inc.Does PIP2 Depletion Change Channel Gating
Properties?
A preliminary examination revealed only modest effects on
channel gating as plasma membrane PIP2 was depleted or
raised. Some speeding of the development of VDI by PIP2 deple-
tion is shown in Figure 9A, again using our a/b pulse protocols
but with longer test pulses. In control cells without Dr-VSP, the
+120 mV/1 s depolarizing pulse had no effect on the time
constant of VDI development during the subsequent 500 ms
test pulse (Figure 9A, top panels). For CaV1.3 channels, the
time constant (t) of inactivation was 200 ± 27 s (n = 5) versus
193 ± 22 s (n = 5), in pulses a and b, respectively, and for
CaV2.2 channels, t values were 44 ± 1 s versus 42 ± 1 s (n = 5).
However, with Dr-VSP, the time constant of inactivation was
shortened, especially for CaV2.2 channels (49 ± 4 s versus
25 ± 2 s for currents a and b, n = 5, *p < 0.001) (Figure 9A, bottom
right). We note that test-pulse depolarizations to +10 mV
produced no change in PH-domain FRET signals and thus do
not activate Dr-VSP (Figure S2D). For CaV2.2 channels, we
also explored effects of an increase in membrane PIP2 levels
Neuron
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2+ Channelsby overexpressing the enzyme PIPKIg. With elevated PIP2, the
development of VDI was slowed by 1.7-fold at +10 mV and
slowed by 2-fold at +30 mV compared to control (Figures 9B
and 9C). The activation of CaV2.2 channels was also slowed
with expression of PIPKIg, delaying the time to peak current
(Figures 9D, S5A, and S5B). Finally, effects on the voltage
dependence of activation were small. When PIP2 was depleted
by the combination of Dr-VSP and AMP-PCP, the voltage
dependence of activation of CaV1.3 channels was not changed
and that for CaV2.2 channels showed a statistically insignificant
left shift (Figures S5C and S5D). On the other hand, when PIP2
was augmented by PIPKIg, the current-voltage relation for
CaV2.2 channels was significantly right shifted by 5–7 mV
(Figure 9E). None of these small gating changes is sufficient to
account for the large depression of currents that we have
described following PIP2 depletion. Rather it seems that with
reduced PIP2, fewer CaV channels are available to open.
DISCUSSION
Using direct enzymatic methods to modify PIP2 levels quickly in
living cells, we have developed compelling support for the
hypothesis that the endogenous PIP2 of a cell maintains a high
activity of CaV1.2, CaV1.3, CaV2.1, and CaV2.2 channels and
that physiological reductions of PIP2 immediately decrease the
channel activity: (1) irreversible depletion of endogenous
membrane PIP2 using iRap-induced translocation of INP54p
5-phosphatase to the plasma membrane irreversibly decreased
the whole-cell CaV currents. (2) Reversible depletion of mem-
brane PIP2 by the activation of Dr-VSP reversibly decreased
CaV currents in less than 1 s, with little change in voltage-depen-
dent channel gating. (3) Elevating levels of membrane PIP2 by
transfecting with PIP 5-kinase significantly blunted the channel
inhibition by Dr-VSP and accelerated recovery from inhibition
4-fold. (4) Attenuating the endogenous PIP 5-kinase activity
using nonhydrolyzable ATP analogs had parallel inhibitory
effects on measured PIP2 resynthesis and on recovery of chan-
nels from inhibition. And (5) the Dr-VSP-mediated PIP2 depletion
and the channel inhibition, as well as subsequent PIP2 resynthe-
sis and channel recovery, developed with similar time courses in
single cells. This correspondence was especially tight for CaV1.3
channels. The loss of CaV1.3 current tracks the loss of PIP2
within milliseconds. Together these new observations show
that the activities of several HVA CaV channels depend on
endogenous membrane PIP2 in intact cells. This is the first direct
evidence that L-type channels participate in such regulation. As
a caveat, we note that we are reporting tests with the b3 and
a2d1 accessory subunits and specific splice variants of the a1
subunits. Since several forms of channel modulation are known
to be affected by the subtypes of each subunit, the quantitative
conclusions here can be applied strictly only to the subunits we
actually tested (e.g., Raingo et al., 2007).
Membrane PIP2 Is a Modulatory Cofactor
for CaV Channel Activity
The central question that motivated our study is whether a
downstream signal of PLCb, PIP2 depletion, is important for
signaling to CaV channels. We have studied the most prominentCaV channel types of native rat SCG neurons a1B/b3/a2d1
(CaV2.2e[37b]) and a1D/b3/a2d1 (CaV1.3e) (Lin et al., 1996; Bell
et al., 2004) in reconstituted systems. Our data show how mem-
brane PIP2 turnover modulates these HVA CaV channels in living
cell membranes and reveal similarities and novel differences
between various subtypes of CaV channels in the modulation
by PIP2. The activity of these channels is significantly decreased
by conversion of PIP2 to PIP and remains inhibited until the
PIP2 is resynthesized from PIP by endogenous PIP 5-kinases.
Thus the anionic phosphoinositide PIP2 is a cofactor required
for full channel activity. Our data suggest that the channels
must be in equilibrium with plasma membrane pools of PIP2 on
a time scale much shorter than the 100 ms that it takes for
Dr-VSP to depress their currents. There must be a protein-lipid
binding interaction of low affinity. The short time intervening
between PIP2 dephosphorylation and the channel response
argues against indirect actions such as downregulation of chan-
nels by endocytosis. Themagnitude of inhibition is greater viaM1
receptors than with exogenous 5-phosphatase-dependent PIP2
depletion.
Our experiments with intact cells did not duplicate all the
phenomena reported for excised patches with CaV2.1 and
CaV2.2 channels (Wu et al., 2002; Gamper et al., 2004). In the
excised patch experiments, tail currents ran down nearly
100% in 2min, and almost all of the tail current could be restored
by direct addition of PIP2. Further, the addition of PIP2 induced
a rightward shift by 40 mV in the voltage dependence of
channel activation. Finally the rightward shift was blocked in
conditions favoring phosphorylation by cAMP-dependent
protein kinase. In the intact-cell experiments of Gamper et al.
(2004) and in our experiments, depletion of PIP2 suppressed
current only partially and any rightward shift with excess PIP2
was <10 mV. Perhaps in whole-cell experiments, some channel
phosphorylations are preserved, or possibly other cytoplasmic
factors make the channels less drastically PIP2 sensitive.
Perhaps also continuing PIP2 synthesis prevents full depletion
of the PIP2. Indeed, when we did experiments with nonhydrolyz-
able ATP analogs, the inhibition by VSP tended to be larger and
cumulative.
Activating Dr-VSP removes the 5 phosphate from PIP2 and
produces a transient rise of membrane PI(4)P that then decays
as it is converted back into PIP2 (Halaszovich et al., 2009). Our
finding that channel currents fall during the transient PIP2
depletion means that PI(4)P is not as effective as PIP2 in support-
ing channel activity. Since currents are inhibited by only
33%–60% for the three channels studied, it is still possible that
the elevated PI(4)P or other acidic phospholipids also support
channel activity but significantly less well than resting levels of
PIP2. Direct experiments with other enzymes would be needed
to test that hypothesis.
In our experiments, N-type channels were inhibited more than
L-type channels by PIP2 depletion, both by iRap-induced
translocation and by Dr-VSP. Unexpectedly, the maximum inhi-
bition by Dr-VSP was 25%–35% larger than the inhibition by
iRap-induced phosphatase translocation. We suggest that the
difference arises from a small basal PIP2 5-phosphatase activity
of the translocatable INP54p that partially depletes membrane
PIP2 already before rapamycin is added. According to our kineticNeuron 67, 224–238, July 29, 2010 ª2010 Elsevier Inc. 235
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2+ Channelsmodels (Suh et al., 2004), even a 1% resting activity at the
membrane would lower the PIP2 level by 20%, enough to reduce
the channel currents partially. This would make the subsequent
iRap-induced inhibition smaller. Thus, we estimate using the
Dr-VSP results that about 55% of CaV2.2 and 35% of CaV1.2
and CaV1.3 current is lost when endogenous PIP2 is depleted.
By comparison, about 75% of CaV2.2 and 55%–65% of
CaV1.2 and CaV1.3 current is lost when M1 muscarinic receptors
are activated. We propose that a significant fraction but not the
entire muscarinic inhibition is due to PIP2 depletion. Previously,
we and others showed that activation of M1 or M3 muscarinic
receptors significantly depletes membrane PIP2 (Willars et al.,
1998; Horowitz et al., 2005; Winks et al., 2005; Jensen et al.,
2009). The depletion is >>90% as assayed by translocation or
loss of FRET from PH-domain probes and by direct biochemical
methods. In this multiple-pathway theory of muscarinic inhibi-
tion, there would also be several components to the postagonist
recovery as each of the underlying messenger systems make its
own recovery. Commonly discussed additional candidate
messengers that do act on CaV1 or CaV2 family channels are
divalent ions, Gbg subunits, arachidonic acid, and protein kinase
C (Delmas et al., 2005; Michailidis et al., 2007; Roberts-Crowley
et al., 2009). The alternative hypothesis, which we regard as
unlikely on kinetic grounds, is that stronger inhibition by PLC
simply reflects an inability of our phosphatases tools to deplete
PIP2 as much as PLC does.
Mechanisms for the PIP2 Actions on CaV Channels
What is PIP2 loss doing to channels to decrease the net current
they carry? We considered two possibilities with negative
results. We considered whether PIP2 loss makes channels
more susceptible to modulation by Gbg subunits. This possibility
seems unlikely both because the PIP2 effect was unchanged in
mutant channels where the Gbg binding site was crippled and
because the inhibition by PIP2 depletion was not relieved by
large positive ‘‘facilitating’’ pulses the way Gbg inhibition would
be. We also considered whether PIP2 loss enhances VDI enough
to account for the suppression of Ca2+ currents. Although PIP2
depletion did speed development of VDI and PIP2 augmentation
slowed it, the component of inhibition due to PIP2 depletion was
not reversed by large hyperpolarizing conditioning pulses that
were sufficient to remove normal VDI.
Our kinetic results with Dr-VSP suggest that CaV1.3 channel
activity follows changes in the membrane PIP2 level closely
in a simple linear manner. They can be described by a model
with low-affinity, rapid, first order, noncooperative binding of
PIP2 to CaV1.3 channels, where each bound PIP2 contributes
a certain increment to the channel activity. Our data would be
consistent with a model having only one facilitatory PIP2 site
on CaV1.3 channels, but there also could be several. The
CaV2.2 channels behave differently. Their activity possibly falls
faster than PIP2 is depleted and certainly recovers much slower
than PIP2 is regenerated. Such behavior could reflect a combina-
tion of a need for more than one bound PIP2 for activity, slow
rebinding of PIP2 to channels, or the involvement of other
PIP2-sensitive messenger signals. Working with CaV2.1 chan-
nels, Wu et al. (2002) considered a model with two PIP2 binding
sites, one with facilitatory and the other with inhibitory effects.236 Neuron 67, 224–238, July 29, 2010 ª2010 Elsevier Inc.Our experiments were done very differently from theirs, and
our data are insufficient to discuss such details, but we did not
encounter any compelling evidence for inhibitory actions of
PIP2. The structure, number, and influences of PIP2 binding sites
on any ion channels are questions for future work, but as a
working hypothesis we would consider a model with at least
two facilitatory sites on the CaV2.2 channel complex both of
which need to be occupied to see enhancement by PIP2. That
would make cooperative kinetics in which channel activity falls
faster than PH domain FRET ratio during inhibition and rises
more slowly than FRET ratio during recovery.Conclusions
Slow modulation of Ca2+ channels by M1 muscarinic receptors
and more generally by any Gq-coupled receptor uses multiple
signaling pathways. We employed a strategy that keeps the
cell intact yet is able to vary membrane PIP2 quickly with
minimum production of other distracting messages, especially
with a novel use of a voltage-dependent phosphatase. We
compensated for effects of voltage-dependent inactivation of
channels on the test current amplitudes. Depending on the
channel subtype, such focused experiments demonstrate that
35%–55% of the Ca2+ channel activity is supported by PIP2 as
a cofactor. The channels do not fail with acutely reduced PIP2
but they definitely generate larger currents when PIP2 is at its
normal endogenous level. Activation of M1Rs removes more
current than just the PIP2-dependent component, but the
PIP2-dependent component accounts for more than half of the
muscarinic modulation. Our early proposal (Bernheim et al.,
1991; Mathie et al., 1992; Hille, 1994) that slow modulation of
KCNQ channels and L- and N-type channels in sympathetic
ganglion cells share a common pathway is partly borne out.
They do use a common pathway, but the Ca2+-channel modula-
tion also uses additional signals. In sum, the PIP2 hypothesis has
now been proven for four voltage-gated Ca2+ channel subtypes
that are modulated by M1 muscarinic receptors, and it has been
shown not to apply to four other CaV subtypes that are not
modulated by M1 muscarinic receptors.EXPERIMENTAL PROCEDURES
Cell Culture and Transfection
TsA201 cells (large-T-antigen transformed HEK293 cells) were maintained in
DMEM supplemented with 10% FBS and 0.2% penicillin/streptomycin and
transiently transfected using Lipofectamine 2000 (Invitrogen) with various
cDNAs (see Supplemental Experimental Procedures). For Ca2+ channel
expression, cells were transfected with the a1 subunit of CaV, b3, and a2d1
in a 1:1:1 molar ratio. When needed, 0.1 mg of cDNA encoding green fluores-
cent protein (GFP) or tetrameric red FP (DsRed) was cotransfected with the
cDNA as a marker for successfully transfected cells. The next day, the cells
were plated onto poly-L-lysine-coated coverslip chips, and fluorescent cells
were studied within 1–2 days in FRET and electrophysiological experiments.
Cultured SCG neurons were prepared as described (Mochida et al., 2003).
Briefly, ganglia were dissected from 7 day postnatal rats, desheathed, and
incubated with collagenase (0.65 mg/ml; Worthington Biochemical) in L-15
medium (GIBCO) at 37C for 40 min. Following enzyme treatment, ganglia
were triturated gently through a small-pore glass pipette, washed twice by
low speed centrifugation, and resuspended in DMEM supplemented with
10% fetal calf serum (GIBCO), 5% horse serum (GIBCO), 1% penicillin-strep-
tomycin solution (GIBCO), and 25 ng/ml nerve growth factor (2.5 S; Alomone
Neuron
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2+ ChannelsLabs Ltd.). Cells were plated on glass coverslips coated with poly-D-lysine in
35 mm dish incubated at 37C (5% CO2). cDNA encoding Dr-VSP was
microinjected into the nuclei of SCG neurons through glass micropipettes
one week after plating. Successful injection was monitored by 5% fast green
dye in the nucleus. N-type currents were recorded two days after injection
of cDNA.
Current Recording
The whole-cell configuration of the patch-clamp technique was used to
voltage-clamp and dialyze cells at room temperature (22–25C). Electrodes
pulled from glass micropipette capillaries (Sutter Instrument, Novato, CA)
had resistances of 1.3–2.5 MU. The whole-cell access resistance was 2–5
MU, and series-resistance errors were compensated >60%. Fast and slow
capacitance was compensated prior to the applied test-pulse sequences.
Ba2+ currents were recorded by holding the cell at –70 mV or –80 mV and
applying 10-ms (or 500-ms in Figure 9) test pulses to –10 mV or +10 mV to
measure CaV1.3 and CaV2.2 or CaV1.2 currents, respectively. Note that tsA
cells do not have endogenous voltage-gated Ca2+ channels and all the inward
Ba2+ current was completely blocked by application of 30 mM Cd2+. In the
experiments with pipette solutions containing the ATP analogs AMP-PCP or
AMP-PNP, wewaited longer than 3min before activating VSP proteins to allow
time for the dialysis of the analogs into the cytoplasm.
Solutions and Materials
The external Ringer’s solution used for Ba2+ current recording and photometry
contained (in mM): 150 NaCl, 10 BaCl2, 1 MgCl2, 10 HEPES, and 8 glucose
(adjusted to pH 7.4 with NaOH). The pipette solution contained (in mM):
175 CsCl, 5 MgCl2, 5 HEPES, 0.1 1,2-bis(2-aminophenoxy)ethane
N,N,N’,N’-tetraacetic acid (BAPTA), 3 Na2ATP, and 0.1 Na3GTP (titrated to
pH 7.4 with CsOH). For current measurements through Ca2+ channels in
SCG neurons, the bath solution contained (in mM) 162.5 tetraethylammonium
(TEA) chloride, 5 BaCl2, 10 HEPES, 8 glucose, 1 MgCl2, 0.0001 TTX, and 0.005
nimodipine (pH adjusted to 7.4 with TEAOH). Variations on the solutions are
noted in text. Reagents were obtained as follows: oxotremorine methiodide
(Oxo-M) (Research Biochemicals, Natick, MA); BAPTA (Molecular Probes,
Eugene, OR); DMEM, fetal bovine serum, lipofectamine 2000, and penicillin/
streptomycin (Invitrogen, Carlsbad, CA); ATP, GTP, AMP-PCP, AMP-PNP,
and other chemicals (Sigma, St. Louis, MO).
Epifluorescence Photometry
Fluorescence resonance energy transfer (FRET) between CFP and YFP was
measured in single cells using an epifluorescence microscope equipped
with two photomultipliers in photon-counting mode as described previously
(Jensen et al., 2009). Cells were studied on the inverted microscope using
a 403, 1.3 numerical aperture oil-immersion objective. Excitation arc light
passed through a 0.2 ND filter and a cube with a 440 ± 10 nm excitation filter
and a 465 nm dichroic mirror. The total emitted light from the entire cell image
was pooled and counted after deflection to the photomultiplier tubes by two
cubes in series: a 505 nmdichroic mirror with a 480 ± 15 nm filter (‘‘short-wave-
length channel’’), and a 570 nm dichroic mirror with a 535 ± 12.5 nm band-
pass filter (‘‘long-wavelength channel’’). For sampling, the illumination shutter
was opened for 24 ms every 500 ms. The fluorescence ratio was taken as the
ratio of long-wavelength to short-wavelength emission (YFPC/CFPC) during
440 nm illumination after corrections for background fluorescence and bleed-
through determined in separate experiments on cells transfected with single
fluorophores. The subscript C is a reminder that the 440 nm excitation light
is exciting CFP in both cases.
Data Analysis
Data acquisition and analysis used Pulse/Pulse Fit 8.11 software in combina-
tion with an EPC-9 patch clamp amplifier (HEKA, Lambrecht, Germany).
Further data processing was performed with Excel (Microsoft, Bellevue, WA)
and Igor Pro (WaveMetrics, Lake Oswego, OR). Time constants were
measured by exponential fits. All quantitative data are expressed as the
mean SEM. Comparison between two groups was analyzed using Student’s
t test, and differences were considered significant at a level p < 0.05.SUPPLEMENTAL INFORMATION
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